| 產品名稱 |
Influenza B virus |
| 商品貨號 |
B203438 |
| Classification |
Orthomyxoviridae, Influenzavirus B |
| Agent |
Influenza B virus |
| Strain |
B/R5 |
| Applications |
Influenza Research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
Recombinant of B/Hong Kong/8/73 (ATCC VR-792) and influenza B/Brigit (ATCC VR-786) |
| Product Format |
frozen |
| Storage Conditions |
-60°C or colder |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Comments |
Influenza strain B/Hong Kong/8/73 antigenicity, negative hemagglutinin thermosensitivity at 60C. |
| Effect on Host |
Yes, in vitro effects: Hemagglutination activity HA activity |
| Recommended Host |
8 to 11 day chicken embryo, i.a. inoculation Recommended Host:? CE (8-11 days, i.a.). Host Range: CE Host Range: CE chicken embryo |
| Growth Conditions |
Temperature: 37.0°C Duration: 1-4 days |
| Name of Depositor |
R.I.T. - Recherche et Industrie Therapeutiques |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Source |
Recombinant of B/Hong Kong/8/73 (ATCC VR-792) and influenza B/Brigit (ATCC VR-786) |
| References |
Peetermans J, et al. Live influenza type B virus vaccines and preparation thereof. US Patent 3,962,423 dated Jun 8 1976
|
